PL374481A1 - Środek do leczenia cukrzycy - Google Patents

Środek do leczenia cukrzycy

Info

Publication number
PL374481A1
PL374481A1 PL03374481A PL37448103A PL374481A1 PL 374481 A1 PL374481 A1 PL 374481A1 PL 03374481 A PL03374481 A PL 03374481A PL 37448103 A PL37448103 A PL 37448103A PL 374481 A1 PL374481 A1 PL 374481A1
Authority
PL
Poland
Prior art keywords
ghs
antagonist
active ingredient
prophylactic
therapeutic
Prior art date
Application number
PL03374481A
Other languages
English (en)
Inventor
Akio Inui
Akihiro Asakawa
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Publication of PL374481A1 publication Critical patent/PL374481A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mirrors, Picture Frames, Photograph Stands, And Related Fastening Devices (AREA)
  • External Artificial Organs (AREA)
PL03374481A 2002-07-05 2003-07-03 Środek do leczenia cukrzycy PL374481A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002197582 2002-07-05

Publications (1)

Publication Number Publication Date
PL374481A1 true PL374481A1 (pl) 2005-10-31

Family

ID=30112403

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03374481A PL374481A1 (pl) 2002-07-05 2003-07-03 Środek do leczenia cukrzycy

Country Status (15)

Country Link
US (1) US20060276381A1 (pl)
EP (1) EP1541171B1 (pl)
JP (1) JP5113320B2 (pl)
KR (1) KR20050039829A (pl)
CN (1) CN1681532A (pl)
AT (1) ATE481133T1 (pl)
AU (1) AU2003246261A1 (pl)
BR (1) BR0312463A (pl)
CA (1) CA2493906A1 (pl)
DE (1) DE60334225D1 (pl)
ES (1) ES2351856T3 (pl)
MX (1) MXPA05000160A (pl)
PL (1) PL374481A1 (pl)
RU (1) RU2005102923A (pl)
WO (1) WO2004004772A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803768B2 (en) 2005-02-23 2010-09-28 Kyoto University Method for treatment of hyperglycemia in a subject in need thereof
EP2021015A2 (en) * 2006-04-28 2009-02-11 The Administrators Of The Tulane Educational Fund Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
CN101646448B (zh) 2007-03-12 2017-02-08 雪印惠乳业株式会社 生长激素分泌促进剂
CN101951937A (zh) * 2007-12-21 2011-01-19 赫尔辛医疗股份公司 使用伊帕瑞林刺激胃肠系统动力的方法
WO2010022213A2 (en) * 2008-08-22 2010-02-25 Elixir Pharmaceuticals, Inc. Compositions and methods for preserving pancreatic islet mass
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
US20120301463A1 (en) 2009-09-30 2012-11-29 President And Fellows Of Harvard College Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
EP2493910A1 (en) 2009-10-30 2012-09-05 Tranzyme Pharma, Inc. Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001056592A1 (en) * 2000-02-01 2001-08-09 Novo Nordisk A/S Use of compounds for the regulation of food intake
US20010020012A1 (en) * 2000-02-01 2001-09-06 Andersen Maibritt Bansholm Use of compounds for the regulation of food intake
EP1286697A2 (en) * 2000-05-17 2003-03-05 Eli Lilly And Company Method for selectively inhibiting ghrelin action
US6967237B2 (en) * 2000-05-30 2005-11-22 Merck & Co., Inc. Ghrelin analogs
JP4493913B2 (ja) * 2001-01-31 2010-06-30 中外製薬株式会社 低栄養症状疾患治療剤
US6949261B2 (en) * 2002-11-12 2005-09-27 Ayurvedic-Life International, Llc Compositions for diabetes treatment and prophylaxis

Also Published As

Publication number Publication date
DE60334225D1 (de) 2010-10-28
WO2004004772A1 (ja) 2004-01-15
ATE481133T1 (de) 2010-10-15
EP1541171A4 (en) 2008-04-09
MXPA05000160A (es) 2006-02-28
EP1541171B1 (en) 2010-09-15
JP5113320B2 (ja) 2013-01-09
ES2351856T3 (es) 2011-02-11
JPWO2004004772A1 (ja) 2005-11-04
RU2005102923A (ru) 2005-10-10
EP1541171A1 (en) 2005-06-15
CA2493906A1 (en) 2004-01-15
AU2003246261A1 (en) 2004-01-23
KR20050039829A (ko) 2005-04-29
CN1681532A (zh) 2005-10-12
BR0312463A (pt) 2005-04-26
US20060276381A1 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
SI1845095T1 (sl) Derivati 1 - tio - D - glukitola
WO2002081453A8 (fr) Hiohydantoïnes et leur utilisation dans le traitement du diabete
NO20060908L (no) Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse
WO2004072031A3 (en) Phenylacetamides and their use as glucokinase modulators
HUP0303876A3 (en) Preparation of pharmaceutical compositions for treatment of type 2 diabetes using piperidine or tiazolidine, inhibitors of dipeptidyl peptidase iv
NO20072389L (no) Substituerte benzokinolizinderivater
NO20055680L (no) Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
NO20070213L (no) Glucagon reseptorantagonister, fremstilling og terapeutiske anvendelser
WO2005044192A3 (en) Triazole compounds and uses related thereto
DK1675591T3 (da) Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer
NO20065926L (no) Substituerte oksazolbenzoisotiazoldioksidderivater samt fremgangsmate for fremstilling og anvendelse derav
WO2007065808A3 (en) Neuropeptide-2 receptor-agonists
EP1568380A4 (en) PREVENTION OR TREATMENT OF DISEASES DUE TO HYPERGLYCEMIA
UA84896C2 (ru) Производные гидронопола как агонисты человеческих рецепторов orl1
WO2002042271A3 (en) Biphenylcarboxamides useful as lipid lowering agents
PL374481A1 (pl) Środek do leczenia cukrzycy
WO2005082893A3 (en) Histamine h3 receptor antagonists, preparation and therapeutic uses
JO2390B1 (en) Diphenylcarboxamides act as lipid-lowering agents
IL176171A0 (en) N-aryl piperidine substituted biphenylcarboxamides
WO2004024066A3 (en) Method of treating diabetes and related conditions
WO2004026837A3 (en) Histamine h3 receptor antagonists, preparaton and therapeutic uses
NO20061702L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og en ostrogen agonist/antagonist
WO2003072572A8 (en) Beta3-adrenergic receptor agonists
WO2003089449A3 (fr) Composes aminoalkylsteroles avec activite anti-tumeur et neuroprotective
TWI256952B (en) Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)